loader
Please Wait
Applying Filters...
menu
    • menu

    Looking for Controlled & Modified Release? Find Controlled & Modified Release Agents used in Temozolomide to address drug delivery challenges on PharmaCompass.

    Evonik

    Virtual Booth

    Contact Supplier

    View Presentation

    Fishfa Biogenics: Renowned Manufacturer, & Exporter of Tacrolimus & Mupirocin API.

    Virtual Booth

    Contact Supplier

    xyz-pharma-m-Default-Wallpaper

    Virtual Booth

    Contact Supplier

    Valsynthese, part of the SSE Group, is a CDMO focused on highly energetic and highly hazardous chemistry.

    Virtual Booth

    Contact Supplier

    Transo-Pharm GmbH works globally to supply Active Pharmaceutical Ingredients adhering to the highest quality & GMP standards.

    Virtual Booth

    Contact Supplier

    xyz-pharma-m-Default-Wallpaper

    Virtual Booth

    Contact Supplier

    Menu

    Temozolomide

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    INTERMEDIATES

    FINISHED DOSAGE FORMULATIONS

    DRUG PRODUCT COMPOSITIONS

    RELATED EXCIPIENT COMPANIES

    EXCIPIENTS BY APPLICATIONS

    DIGITAL CONTENT

    GLOBAL SALES INFORMATION

    MARKET PLACE

    PATENTS & EXCLUSIVITIES

    REF. STANDARDS & IMPURITIES

    PharmaCompass
    $ API Ref.Price (USD/KG) : 6,755Xls

    Filters

    clear-filterReset all filters
    Filters Filter
    Cross PopUp
    FILTER :

    filter clear-filterReset all filters

    01 2Gangwal Healthcare

    02 5Nanjing Well Pharmaceutical

    03 6Actylis

    04 20BASF

    05 4Finar

    06 2Nomisma Healthcare

    filter clear-filterReset all filters

    filter clear-filterReset all filters

    PharmaCompass

    01

    Gangwal Healthcare

    India
    arrow
    CPhI India 2024
    Booth #8.Q10
    • fda
    • EDQM
    • WHO-GMP

    Virtual BoothGangwal Healthcare is powered by innovation, driving health, wellness & healing.

    Dosage Form : Capsule, Tablet

    Grade : Oral

    Brand Name : DiCOM-DC® SR300

    Application : Co-Processed Excipients, Controlled & Modified Release, Direct Compression

    Excipient Details : DiCOM-DC SR300 is used as a directly compressible, rate-controlling, and co-processed excipient in sustained-release tablets and capsules.

    Pharmacopoeia Ref : In-house

    Technical Specs : NA

    Ingredient(s) : EthylCellulose, Hydroxypropyl Cellulose, Hydroxypropyl Methylcellulose, Magnesium Stearate, Maize Starch, Microcrystalline Cellulose, Silicon Dioxide, Talc

    Dosage Form : Capsule, Tablet

    Grade : Oral

    arrow
    • fda
    • EDQM
    • WHO-GMP

    Virtual BoothGangwal Healthcare is powered by innovation, driving health, wellness & healing.

    Ingredient(s) : EthylCellulose, Hydroxypropyl Cellulose, Hydroxypropyl Methylcellulose, Magnesium Stearate, Maize Starch, Microcrystalline Cellulose, Silicon Dioxide, Talc

    Dosage Form : Capsule, Tablet

    Category : Co-Processed Excipients, Controlled & Modified Release, Direct Compression

    Brand : DICOM-DC® SR300

    Applications : DiCOM-DC SR300 is used as a directly compressible, rate-controlling, and co-processed excipient in sustained-release tablets and capsules.

    Pharmacopoeia Ref : In-house

    Technical Specs : NA

    Grade : Oral

    arrow
    Gangwal Healthcare DiCOM-DC® SR300

    Excipients Web Link

    Market Place

    Digital Content

    Virtual Booth

    02

    Nanjing Well Pharmaceutical

    China
    arrow
    2024 ACI Convention
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP

    Virtual BoothNanjing Well is focused on R&D, production & sales of Pharmaceutical Excipients & Synthetic Lubricating base oils.

    Dosage Form : Cream / Lotion / Ointment, Gel, Injectable / Parenteral, Softgel Capsule, Softgels

    Grade : Parenteral, Topical, Oral

    Brand Name : Polyethylene Glycol 400

    Application : Fillers, Diluents & Binders, Film Formers & Plasticizers, Parenteral, Surfactant & Foaming Agents, Thickeners and Stabilizers, Topical

    Excipient Details : PEG 400 is used as a suspending agent, stabilizer, plasticizer and filler in OSDs, liquids & semi-solids and as a solvent for parenteral formulations.

    Pharmacopoeia Ref : ChP/USP/EP

    Technical Specs : NA

    Ingredient(s) : Polyethylene Glycol 400

    Dosage Form : Cream / Lotion / Ointment, Gel, Injectable / Parenteral, Softgel Capsule, Softgels

    Grade : Parenteral, Topical, Oral

    arrow
    • fda
    • EDQM
    • WHO-GMP

    Virtual BoothNanjing Well is focused on R&D, production & sales of Pharmaceutical Excipients & Synthetic Lubricating base oils.

    Ingredient(s) : Polyethylene Glycol 400

    Dosage Form : Cream / Lotion / Ointment, Gel, Injectable / Parenteral, Softgel Capsule, Softgels

    Category : Fillers, Diluents & Binders, Film Formers & Plasticizers, Parenteral, Surfactant & Foaming Agents, Thickeners and Stabilizers, Topical

    Brand : POLYETHYLENE GLYCOL 400

    Applications : PEG 400 is used as a suspending agent, stabilizer, plasticizer and filler in OSDs, liquids & semi-solids and as a solvent for parenteral formulations.

    Pharmacopoeia Ref : ChP/USP/EP

    Technical Specs : NA

    Grade : Parenteral, Topical, Oral

    arrow
    Nanjing Well Polyethylene Glycol 400 NF

    Excipients Web Link

    Market Place

    Digital Content

    Virtual Booth

    03

    Nomisma Healthcare

    PLLA-PEG

    arrow
    2024 ACI Convention
    Not Confirmed

    04

    BASF

    KOLLIDON SR

    arrow
    2024 ACI Convention
    Not Confirmed

    BASF

    Germany
    arrow
    2024 ACI Convention
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    Dosage Form : Capsule, Tablet, Topical Film, Transdermal Patch

    Grade :

    Brand Name : Kollidon SR

    Application : Controlled & Modified Release, Direct Compression, Granulation

    Excipient Details : For non-erodible matrices using direct compression, Controlled release matrix. Matrix former in transdermal patches and topical films.

    Pharmacopoeia Ref : Ph. Eur., USP-NF, JP-JPE: 80 %...

    Technical Specs :

    Ingredient(s) : Hydrated Silica, Lauryl Sulfate, Polyvinyl Acetate, Povidone

    Dosage Form : Capsule, Tablet, Topical Film, Transdermal Patch

    Grade :

    arrow
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    Ingredient(s) : Hydrated Silica, Lauryl Sulfate, Polyvinyl Acetate, Povidone

    Dosage Form : Capsule, Tablet, Topical Film, Transdermal Patch

    Category : Controlled & Modified Release, Direct Compression, Granulation

    Brand : KOLLIDON SR

    Applications : For non-erodible matrices using direct compression, Controlled release matrix. Matrix former in transdermal patches and topical films.

    Pharmacopoeia Ref : Ph. Eur., USP-NF, JP-JPE: 80 % Polyvinyl acetate and 19 % povidone, 0.8 % lauryl sulfate & 0.2 % silica (4:1)

    Technical Specs : Not Available

    Grade : Not Available

    arrow
    blank

    Excipients Web Link

    Market Place

    Digital Content

    Virtual Booth

    05

    Nomisma Healthcare

    PLGA-PEG

    arrow
    2024 ACI Convention
    Not Confirmed

    Nomisma Healthcare

    India
    arrow
    2024 ACI Convention
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    Dosage Form : Tablet

    Grade : Oral, Parenteral

    Brand Name : PLGA-PEG

    Application : Controlled & Modified Release

    Excipient Details : PLGA-PEG is used in the synthesis of targeted nanoparticles which are used for differential delivery and controlled release of drugs.

    Pharmacopoeia Ref : NA

    Technical Specs : Nano-particles, ultrapure, low-monomer & powder grades.

    Ingredient(s) : Poly-DL-Lactic-co-Glycolic Acid, Polyethylene Glycol Excipients

    Dosage Form : Tablet

    Grade : Oral, Parenteral

    arrow
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    Ingredient(s) : Poly-DL-Lactic-co-Glycolic Acid, Polyethylene Glycol Excipients

    Dosage Form : Tablet

    Category : Controlled & Modified Release

    Brand : PLGA-PEG

    Applications : PLGA-PEG is used in the synthesis of targeted nanoparticles which are used for differential delivery and controlled release of drugs.

    Pharmacopoeia Ref : NA

    Technical Specs : Nano-particles, ultrapure, low-monomer & powder grades.

    Grade : Oral, Parenteral

    arrow
    blank

    Excipients Web Link

    Market Place

    Digital Content

    Virtual Booth

    06

    Finar

    POLYETHYLENE GLYCOL 400

    arrow
    2024 ACI Convention
    Not Confirmed

    07

    Actylis

    POLYETHYLENE GLYCOL 400

    arrow
    2024 ACI Convention
    Not Confirmed

    08

    Actylis

    SODIUM CITRATE DIHYDRATE MULTI-COMPENDIAL

    arrow
    2024 ACI Convention
    Not Confirmed

    09

    Actylis

    SODIUM CITRATE DIHYDRATE USP-NF

    arrow
    2024 ACI Convention
    Not Confirmed

    10

    BASF

    KOLLICOAT SR 30 D

    arrow
    2024 ACI Convention
    Not Confirmed

    BASF

    Germany
    arrow
    2024 ACI Convention
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    Dosage Form : Capsule, Granule / Pellet, Softgel Capsule, Tablet, Topical Film

    Grade :

    Brand Name : Kollicoat SR 30 D

    Application : Coating Systems & Additives, Controlled & Modified Release, Taste Masking

    Excipient Details : pH-independent sustained release coating for small particles, pellets, granules and tablets. Sprayable polymeric film former. Flexible. Wash resistant.

    Pharmacopoeia Ref : Ph. Eur.: Poly(vinyl acetate) ...

    Technical Specs :

    Ingredient(s) : Polyvinyl Acetate, Sodium Lauryl Sulfate

    Dosage Form : Capsule, Granule / Pellet, Softgel Capsule, Tablet, Topical Film

    Grade :

    arrow
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    Ingredient(s) : Polyvinyl Acetate, Sodium Lauryl Sulfate

    Dosage Form : Capsule, Granule / Pellet, Softgel Capsule, Tablet, Topical Film

    Category : Coating Systems & Additives, Controlled & Modified Release, Taste Masking

    Brand : KOLLICOAT SR 30 D

    Applications : pH-independent sustained release coating for small particles, pellets, granules and tablets. Sprayable polymeric film former. Flexible. Wash resistant.

    Pharmacopoeia Ref : Ph. Eur.: Poly(vinyl acetate) dispersion 30 per cent; USP: Polyvinyl Acetate Dispersion

    Technical Specs : Not Available

    Grade : Not Available

    arrow
    blank

    Excipients Web Link

    Market Place

    Digital Content

    Virtual Booth

    11

    BASF

    KOLLIDON 25

    arrow
    2024 ACI Convention
    Not Confirmed

    12

    BASF

    KOLLIDON 30

    arrow
    2024 ACI Convention
    Not Confirmed

    13

    BASF

    SOLUPLUS

    arrow
    2024 ACI Convention
    Not Confirmed

    BASF

    Germany
    arrow
    2024 ACI Convention
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    Dosage Form : Solution, Tablet, Topical Film, Transdermal Patch

    Grade :

    Brand Name : Soluplus

    Application : Controlled & Modified Release, Granulation, Solubilizers

    Excipient Details : Solubility and bioavailability enhancement, ideal for hot melt extrusion (HME)

    Pharmacopoeia Ref : Polyvinyl caprolactam – poly...

    Technical Specs :

    Ingredient(s) : polyethylene glycol, Polyvinyl Acetate

    Dosage Form : Solution, Tablet, Topical Film, Transdermal Patch

    Grade :

    arrow
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    Ingredient(s) : polyethylene glycol, Polyvinyl Acetate

    Dosage Form : Solution, Tablet, Topical Film, Transdermal Patch

    Category : Controlled & Modified Release, Granulation, Solubilizers

    Brand : SOLUPLUS

    Applications : Solubility and bioavailability enhancement, ideal for hot melt extrusion (HME)

    Pharmacopoeia Ref : Polyvinyl caprolactam – polyvinyl acetate – polyethylene glycol graft copolymer

    Technical Specs : Not Available

    Grade : Not Available

    arrow
    blank

    Excipients Web Link

    Market Place

    Digital Content

    Virtual Booth